PRELUDE CAPITAL MANAGEMENT, LLC - OPIANT PHARMACEUTICALS INC ownership

OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 29 filers reported holding OPIANT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of OPIANT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$10,000
-23.1%
1,400
-4.6%
0.00%
-100.0%
Q2 2020$13,000
-7.1%
1,4670.0%0.00%0.0%
Q1 2020$14,000
-54.8%
1,467
-32.1%
0.00%0.0%
Q4 2019$31,000
-79.5%
2,162
-81.3%
0.00%
-88.9%
Q1 2019$151,000
-56.9%
11,533
-52.3%
0.01%
-60.9%
Q4 2018$350,00024,1970.02%
Other shareholders
OPIANT PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 210,000$2,518,0005.80%
APIS CAPITAL ADVISORS, LLC 196,000$2,350,0002.65%
Stonepine Capital Management, LLC 152,278$1,826,0000.85%
Parkman Healthcare Partners LLC 75,632$907,0000.33%
PERRITT CAPITAL MANAGEMENT INC 30,500$366,0000.22%
ESSEX INVESTMENT MANAGEMENT CO LLC 50,405$604,0000.10%
ACADIAN ASSET MANAGEMENT LLC 126,978$1,523,0000.01%
Trexquant Investment LP 12,219$147,0000.01%
Renaissance Technologies 193,415$2,319,0000.00%
TWO SIGMA ADVISERS, LP 74,400$892,0000.00%
View complete list of OPIANT PHARMACEUTICALS INC shareholders